Section Arrow
LENZ.NASDAQ
- LENZ Therapeutics
Quotes are at least 15-min delayed:2026/03/02 10:56 EST
Regular Hours
Last
 13.65
+0.14 (+1.04%)
Day High 
13.675 
Prev. Close
13.51 
1-M High
19.8 
Volume 
149.27K 
Bid
13.59
Ask
13.71
Day Low
12.9001 
Open
13.01 
1-M Low
11.48 
Market Cap 
422.73M 
Currency 美元 
P/E -- 
%Yield 32.39 
10-SMA 12.73 
20-SMA 13.59 
50-SMA 15.93 
52-W High 50.4 
52-W Low 11.48 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.06/-0.72
Enterprise Value
423.54M
Balance Sheet
Book Value Per Share
6.20
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IBRXImmunityBio10.475+0.675+6.89%-- 
QNCXQuince Therapeutics0.10645-0.01365-11.37%-- 
QUREuniQure NV10.11-5.47-35.11%-- 
RAPTRAPT Therapeutics Inc57.995+0.015+0.03%-- 
NTLAIntellia Therapeutics14.44+0.67+4.87%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, theinevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.